A Public Option for Clinical Trials? Lessons from Convalescent Plasma

By Victor Roy, Joseph S, Reshma Ramachandran.
COVID-19 Plasma Public Sector

Abstract

The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, can be translated to wider efforts to develop a “public option” for clinical trials.

Link to resource: https://doi.org/10.1017/jme.2024.57

Type of resources: Reading

Education level(s): College / Upper Division (Undergraduates), Graduate / Professional

Primary user(s): Student, Teacher

Subject area(s): Law, Life Science

Language(s): English